M. Guliyev, “Evaluating the Prognostic Role of Pan-Immune-Inflammation Value in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab”, Cerrahpaşa Medical Journal, vol. 49, no. 1, pp. 1–9, Sep. 2025.